Cargando…
Regulatory T Cells in Infection
Infectious agents have intimately co-evolved with the host immune system, acquiring a portfolio of highly sophisticated mechanisms to modulate immunity. Among the common strategies developed by viruses, bacteria, protozoa, helminths, and fungi is the manipulation of the regulatory T cell network in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150045/ https://www.ncbi.nlm.nih.gov/pubmed/22118407 http://dx.doi.org/10.1016/B978-0-12-387827-4.00003-6 |
_version_ | 1783520942440316928 |
---|---|
author | Maizels, Rick M. Smith, Katherine A. |
author_facet | Maizels, Rick M. Smith, Katherine A. |
author_sort | Maizels, Rick M. |
collection | PubMed |
description | Infectious agents have intimately co-evolved with the host immune system, acquiring a portfolio of highly sophisticated mechanisms to modulate immunity. Among the common strategies developed by viruses, bacteria, protozoa, helminths, and fungi is the manipulation of the regulatory T cell network in order to favor pathogen survival and transmission. Treg activity also benefits the host in many circumstances by controlling immunopathogenic reactions to infection. Interestingly, some pathogens are able to directly induce the conversion of naive T cells into suppressive Foxp3-expressing Tregs, while others activate pre-existing natural Tregs, in both cases repressing pathogen-specific effector responses. However, Tregs can also act to promote immunity in certain settings, such as in initial stages of infection when effector cells must access the site of infection, and subsequently in ensuring generation of effector memory. Notably, there is little current information on whether infections selectively drive pathogen-specific Tregs, and if so whether these cells are also reactive to self-antigens. Further analysis of specificity, together with a clearer picture of the relative dynamics of Treg subsets over the course of disease, should lead to rational strategies for immune intervention to optimize immunity and eliminate infection. |
format | Online Article Text |
id | pubmed-7150045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71500452020-04-13 Regulatory T Cells in Infection Maizels, Rick M. Smith, Katherine A. Adv Immunol Article Infectious agents have intimately co-evolved with the host immune system, acquiring a portfolio of highly sophisticated mechanisms to modulate immunity. Among the common strategies developed by viruses, bacteria, protozoa, helminths, and fungi is the manipulation of the regulatory T cell network in order to favor pathogen survival and transmission. Treg activity also benefits the host in many circumstances by controlling immunopathogenic reactions to infection. Interestingly, some pathogens are able to directly induce the conversion of naive T cells into suppressive Foxp3-expressing Tregs, while others activate pre-existing natural Tregs, in both cases repressing pathogen-specific effector responses. However, Tregs can also act to promote immunity in certain settings, such as in initial stages of infection when effector cells must access the site of infection, and subsequently in ensuring generation of effector memory. Notably, there is little current information on whether infections selectively drive pathogen-specific Tregs, and if so whether these cells are also reactive to self-antigens. Further analysis of specificity, together with a clearer picture of the relative dynamics of Treg subsets over the course of disease, should lead to rational strategies for immune intervention to optimize immunity and eliminate infection. Elsevier Inc. 2011 2011-11-23 /pmc/articles/PMC7150045/ /pubmed/22118407 http://dx.doi.org/10.1016/B978-0-12-387827-4.00003-6 Text en Copyright © 2011 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Maizels, Rick M. Smith, Katherine A. Regulatory T Cells in Infection |
title | Regulatory T Cells in Infection |
title_full | Regulatory T Cells in Infection |
title_fullStr | Regulatory T Cells in Infection |
title_full_unstemmed | Regulatory T Cells in Infection |
title_short | Regulatory T Cells in Infection |
title_sort | regulatory t cells in infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150045/ https://www.ncbi.nlm.nih.gov/pubmed/22118407 http://dx.doi.org/10.1016/B978-0-12-387827-4.00003-6 |
work_keys_str_mv | AT maizelsrickm regulatorytcellsininfection AT smithkatherinea regulatorytcellsininfection |